Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States

Bibliographic Details
Title: Demographic differences among patients treated with chimeric antigen receptor T‐cell therapy in the United States
Authors: Josephine Emole, Odunayo Lawal, Oleksandra Lupak, Ajoy Dias, Leyla Shune, Korede Yusuf
Source: Cancer Medicine, Vol 11, Iss 23, Pp 4440-4448 (2022)
Publisher Information: Wiley, 2022.
Publication Year: 2022
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: CART cell therapy, disparities, leukemia, lymphoma, multiple myeloma, sociodemographic factors, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
More Details: Abstract Background It is not clear if all Americans have benefitted equally from the availability of chimeric antigen receptor T‐cell (CART) therapy. We aimed to evaluate if demographic differences existed among adult patients who received CART therapy and to assess predictors of CART treatment outcomes. Methods Records of patients ≥18 years who received CART therapy for non‐Hodgkin’s lymphoma, acute lymphoblastic leukemia, and multiple myeloma in 2018 were evaluated in the National Inpatient Sample. Acute complications and inhospital mortality were compared between two groups of CART recipients: Whites and non‐Whites. Logistic regression analysis was used to evaluate the association between sociodemographic factors and inhospital mortality. Results Of 1275 CART recipients that met inclusion criteria, there were 40.4% of females, 66.9% of Whites, Blacks (4.2%), Hispanics (13.3%), Asians or Pacific Islanders (4.2%), and Native Americans (1.3%). Up to 96.8% of CART procedures were performed in urban teaching hospitals, and 85.3% of CART recipients lived in metropolitan counties. Non‐Whites, compared to Whites, were younger at the time of CART therapy (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-7634
Relation: https://doaj.org/toc/2045-7634
DOI: 10.1002/cam4.4797
Access URL: https://doaj.org/article/0b57202eae1c49b0a131f97167cc4177
Accession Number: edsdoj.0b57202eae1c49b0a131f97167cc4177
Database: Directory of Open Access Journals
More Details
ISSN:20457634
DOI:10.1002/cam4.4797
Published in:Cancer Medicine
Language:English